Etienne Weiss
British Journal of Pharmacology · 2009
A researcher in the Science corpus: 1 paper; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from Etienne Weiss's perspective
Ordered by how strongly the researchers Etienne Weiss trusts endorse each paper. Same corpus, a different order for every researcher.
- Monoclonal antibody successes in the clinic (Nature Biotechnology)
- Targeting and tracing antigens in live cells with fluorescent nanobodies (Nature Methods)
- Engineered antibody Fc variants with enhanced effector function.
- FcRn: the neonatal Fc receptor comes of age
- Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene. (Blood)
- Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma. (Journal of Clinical Oncology)
- Convergent solutions to binding at a protein-protein interface. (Science)
- Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. (Science)
- The Major Histocompatibility Complex–related Fc Receptor for IgG (FcRn) Binds Albumin and Prolongs Its Lifespan (Journal of Experimental Medicine)
- Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein (Nature Biotechnology)
Their papers
- Therapeutic antibodies: successes, limitations and hopes for the future (2009) — 1,366 citations